cgp-37849 has been researched along with 4-trans-2-carboxy-5-7-dichloro-4-phenylaminocarbonylamino-1-2-3-4-tetrahydroquinoline* in 1 studies
1 other study(ies) available for cgp-37849 and 4-trans-2-carboxy-5-7-dichloro-4-phenylaminocarbonylamino-1-2-3-4-tetrahydroquinoline
Article | Year |
---|---|
NMDA receptors with different sensitivities to magnesium and ifenprodil control the release of [14C]acetylcholine and [3H]spermidine from rat striatal slices in vitro.
KCl (20-100 mM) and N-methyl-D-aspartate (NMDA, 100-1,000 microM) produce concomitant concentration-dependent increases in the release of previously captured [14C]acetylcholine and [3H]spermidine from rat striatal slices in vitro. The effects of NMDA (300 microM) on striatal [14C]acetylcholine and [3H]spermidine release were blocked with equal potencies by the competitive NMDA antagonist CGP 37849, the glycine site antagonist L-689,560, and the NMDA channel blocker dizocilpine. In contrast, although NMDA-evoked [14C]acetylcholine release was antagonized by ifenprodil (IC50 = 5.3 microM) and MgCl2 (IC50 = 200 microM), neither compound antagonized the NMDA-evoked release of [3H]spermidine at concentrations up to 100 microM (ifenprodil) or 1 mM (MgCl2). Distinct NMDA receptor subtypes with different sensitivities to magnesium and ifenprodil therefore exist in the rat striatum. Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Aminoquinolines; Animals; Carbon Radioisotopes; Corpus Striatum; Dizocilpine Maleate; Dose-Response Relationship, Drug; In Vitro Techniques; Kinetics; Magnesium; Magnesium Chloride; N-Methylaspartate; Piperidines; Rats; Receptors, N-Methyl-D-Aspartate; Spermidine; Tritium | 1994 |